SCHEMBL13947097

SCHEMBL13947097

Cc1ccc(C(=O)NCc2ccc(Cl)nc2C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ TDP1 Q9NUW8 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ KLKB1 P03952 1/20 0.46
▸ TP53 P04637 2/20 0.46
▸ LMNA P02545 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MAPK14 Q16539 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ NLRP1 Q9C000 1/20 0.45
▸ MMP2 P08253 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ STAT3 P40763 1/20 0.45
▸ MMP13 P45452 1/20 0.45
▸ EPHX2 P34913 2/20 0.44
▸ NR1H4 Q96RI1 2/20 0.44
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13269951 0.82 KLKB1 (0.45) ALDH1A1HTTKLKB1LMNASMN1; SMN2
SCHEMBL13947209 0.80 MAPT (0.52) MAPTALDH1A1TDP1HTTKDM4E
SCHEMBL13117299 0.79 TSHR (0.47) ALDH1A1HTTKLKB1TP53LMNA
SCHEMBL5642926 0.75 LMNA (0.75) MAPTALDH1A1HTTTP53LMNA
SCHEMBL17888306 0.75 PIK3CA (0.55) MAPTALDH1A1TDP1HTTLMNA
SCHEMBL13947406 0.75 MAPT (0.50) MAPTALDH1A1TDP1HTTKDM4E
SCHEMBL13947384 0.75 SMN1; SMN2 (0.73) MAPTALDH1A1KDM4ETP53LMNA
SCHEMBL28372954 0.73 KLKB1 (0.56) HTTKDM4EKLKB1SMN1; SMN2MAPK14
SCHEMBL5645497 0.73 ROCK2 (0.58) LMNAMAPK1NLRP1EPHX2NR1H4
SCHEMBL8900192 0.72 MAPT (0.36) MAPTALDH1A1HTTKLKB1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases MAIER UDO 2009-01-29 — — US disclosed
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 MAPT 4256/4885ALDH1A1 1078/4885TDP1 3846/4885
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 MAPT 4256/4885ALDH1A1 1078/4885TDP1 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback